Large-scale human immunodeficiency virus rapid test evaluation in a low-prevalence ugandan blood bank population.
The use of rapid tests for human immunodeficiency virus (HIV) has become standard in HIV testing algorithms employed in resource-limited settings. We report an extensive HIV rapid test validation study conducted among Ugandan blood bank donors at low risk for HIV infection. The operational characteristics of four readily available commercial HIV rapid test kits were first determined with 940 donor samples and were used to select a serial testing algorithm. Uni-Gold Recombigen HIV was used as the screening test, followed by HIV-1/2 STAT-PAK for reactive samples. OraQuick HIV-1 testing was performed if the first two test results were discordant. This algorithm was then tested with 5,252 blood donor samples, and the results were compared to those of enzyme immunoassays (EIAs) and Western blotting. The unadjusted algorithm sensitivity and specificity were 98.6 and 99.9%, respectively. The adjusted sensitivity and specificity were 100 and 99.96%, respectively. This HIV testing algorithm is a suitable alternative to EIAs and Western blotting for Ugandan blood donors.
Eller
Leigh A
LA
Makerere University Walter Reed Project, Kampala, Uganda. leller@muwrp.org
Eller
Michael A
MA
Ouma
Benson J
BJ
Kataaha
Peter
P
Bagaya
Bernard S
BS
Olemukan
Robert L
RL
Erima
Simon
S
Kawala
Lilian
L
de Souza
Mark S
MS
Kibuuka
Hannah
H
Wabwire-Mangen
Fred
F
Peel
Sheila A
SA
O'Connell
Robert J
RJ
Robb
Merlin L
ML
Michael
Nelson L
NL
D000293:Adolescent; D000328:Adult; D000465:Algorithms; D001771:Blood Banks; D001782:Blood Donors; D005189:False Positive Reactions; D005260:Female; D006678:HIV / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012680:Sensitivity and Specificity
Ann N Y Acad Sci. 2000 Nov;918:64-76
11131736
BMJ. 2007 Jul 28;335(7612):188
17545184
MMWR Morb Mortal Wkly Rep. 2001 Jun 29;50(25):538-41
11446572
J Virol Methods. 2003 Aug;111(2):129-34
12880928
J Clin Microbiol. 2003 Aug;41(8):3868-9
12904405
J Clin Microbiol. 2004 Aug;42(8):3850-2
15297547
JAMA. 1994 Mar 2;271(9):703-7
8309035
J Infect Dis. 1996 Oct;174 Suppl 2:S176-81
8843247
Wkly Epidemiol Rec. 1997 Mar 21;72(12):81-7
9238418
AIDS. 1997 Sep;11 Suppl 1:S103-10
9376093
JAMA. 1998 Apr 15;279(15):1158-9
9555741
Wkly Epidemiol Rec. 1998 Oct 16;73(42):321-6
9803168
J Virol Methods. 2005 Jun;126(1-2):75-80
15847921
J Clin Microbiol. 2005 Oct;43(10):5312-5
16208006
AIDS Behav. 2006 Jul;10(4):335-46; discussion 347-50
16688475
J Clin Microbiol. 2001 May;39(5):1808-12
11325995